| 432 |
[2022 Mar;46(2)] DA-1241, a Novel GPR119 Agonist, Improves Hyperglycaemia by Inhibiting Hepatic Gluconeogenesis and Enhancing Insulin Secretion in Diabetic Mice
|
|
2022.07.15 |
554 |
| 431 |
[2022 Mar;46(2)] Changes in Patterns of Physical Activity and Risk of Heart Failure in Newly Diagnosed Diabetes Mellitus Patients
|
|
2022.07.15 |
584 |
| 430 |
[2022 Mar;46(2)] SUDOSCAN in Combination with the Michigan Neuropathy Screening Instrument Is an Effective Tool for Screening Diabetic Peripheral Neuropathy
|
|
2022.07.15 |
494 |
| 429 |
[2022 Mar;46(2)] Iron Overload and the Risk of Diabetes in the General Population: Results of the Chinese Health and Nutrition Survey Cohort Study
|
|
2022.07.15 |
478 |
| 428 |
[2022 Mar;46(2)] Prevalence of Type 2 Diabetes Mellitus among Korean Children, Adolescents, and Adults Younger than 30 Years: Changes from 2002 to 2016
|
|
2022.07.15 |
522 |
| 427 |
[2022 Mar;46(2)] Mean and Variability of Lipid Measurements and Risk for Development of Subclinical Left Ventricular Diastolic Dysfunction
|
|
2022.07.15 |
479 |
| 426 |
[2022 Mar;46(2)] Performance of Diabetes and Kidney Disease Screening Scores in Contemporary United States and Korean Populations
|
|
2022.07.15 |
490 |
| 425 |
[2022 Mar;46(2)] Impact of COVID-19 Lockdown on the Metabolic Control Parameters in Patients with Diabetes Mellitus: A Systematic Review and Meta-Analysis
|
|
2022.07.15 |
498 |
| 424 |
[2022 Mar;46(2)] Links between Thyroid Disorders and Glucose Homeostasis
|
|
2022.07.15 |
469 |
| 423 |
[2022 Mar;46(2)] Glial and Vascular Cell Regulation of the Blood-Brain Barrier in Diabetes
|
|
2022.07.15 |
457 |
| 422 |
[2022 Mar;46(2)] Peripheral Neuropathy Phenotyping in Rat Models of Type 2 Diabetes Mellitus: Evaluating Uptake of the Neurodiab Guidelines and Identifying Future Directions
|
|
2022.07.15 |
453 |
| 421 |
[2022 Mar;46(2)] Pathophysiologic Mechanisms and Potential Biomarkers in Diabetic Kidney Disease
|
|
2022.07.15 |
477 |
| 420 |
[2022 Mar;46(2)] Not Control but Conquest: Strategies for the Remission of Type 2 Diabetes Mellitus
|
|
2022.07.15 |
474 |
| 419 |
[2022 Jan;46(1)] Do-It-Yourself Open Artificial Pancreas System in Children and Adolescents with Type 1 Diabetes Mellitus: Real-World Data
|
|
2022.07.15 |
497 |
| 418 |
[2022 Jan;46(1)] Real-World Analysis of Therapeutic Outcome in Type 1 Diabetes Mellitus at a Tertiary Care Center
|
|
2022.07.15 |
498 |
| 417 |
[2022 Jan;46(1)] Postprandial Free Fatty Acids at Mid-Pregnancy Increase the Risk of Large-for-Gestational-Age Newborns in Women with Gestational Diabetes Mellitus
|
|
2022.07.15 |
500 |
| 416 |
[2022 Jan;46(1)] Serum Retinol-Binding Protein Levels Are Associated with Nonalcoholic Fatty Liver Disease in Chinese Patients with Type 2 Diabetes Mellitus: A Real-World Study
|
|
2022.07.15 |
468 |
| 415 |
[2022 Jan;46(1)] Influence of Glucose Fluctuation on Peripheral Nerve Damage in Streptozotocin-Induced Diabetic Rats
|
|
2022.07.15 |
485 |
| 414 |
[2022 Jan;46(1)] Renal Tubular Damage Marker, Urinary N-acetyl-β-D-Glucosaminidase, as a Predictive Marker of Hepatic Fibrosis in Type 2 Diabetes Mellitus
|
|
2022.07.15 |
514 |
| 413 |
[2022 Jan;46(1)] Association between Metabolic Syndrome and Microvascular Complications in Chinese Adults with Type 1 Diabetes Mellitus
|
|
2022.07.15 |
471 |
